Cite
Liu ZH, Zhang Q, Ding YJ, et al. Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma. Oncotarget. 2017;8(43):74178-74187doi: 10.18632/oncotarget.18830.
Liu, Z. H., Zhang, Q., Ding, Y. J., Ren, Y. H., Yang, H. P., Xi, Q., Cheng, Y. N., Miao, G. L., Liu, H. K., Li, C. X., Yan, W. Q., Li, Y., Xue, Z., Zhang, L., Li, X. Y., Zhao, C. L., Da, Y., Wu, X. Z., Chen, J. Q., Zhang, R., & Li, Z. G. (2017). Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma. Oncotarget, 8(43), 74178-74187. https://doi.org/10.18632/oncotarget.18830
Liu, Ze-Han, et al. "Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma." Oncotarget vol. 8,43 (2017): 74178-74187. doi: https://doi.org/10.18632/oncotarget.18830
Liu ZH, Zhang Q, Ding YJ, Ren YH, Yang HP, Xi Q, Cheng YN, Miao GL, Liu HK, Li CX, Yan WQ, Li Y, Xue Z, Zhang L, Li XY, Zhao CL, Da Y, Wu XZ, Chen JQ, Zhang R, Li ZG. Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma. Oncotarget. 2017 Jun 29;8(43):74178-74187. doi: 10.18632/oncotarget.18830. eCollection 2017 Sep 26. PMID: 29088777; PMCID: PMC5650332.
Copy
Download .nbib